منابع مشابه
Oxaliplatin-Related Ocular Toxicity
We report the case of a 52-year-old woman with advanced colorectal cancer who was treated with oxaliplatin on a FOLFOX schedule. After 3 cycles of chemotherapy, she started to complain of visual loss, altered color vision and neurological symptoms. Due to the suspicion of ocular and neurological toxicity, antineoplastic treatment was stopped. Her visual field showed a concentric bilateral scoto...
متن کاملExacerbation of oxaliplatin neurosensory toxicity following surgery.
Combination of chemotherapy and surgical resection of metastases is the most promising strategy to improve the fraction of long-term survivors and cured patients in metastatic colorectal cancer. We reproducibly observed evidence of exacerbation of the oxaliplatin-induced neurosensory toxicity following surgery. Total, protein-bound and intra-erythrocytic concentrations of oxaliplatin were measu...
متن کاملOxaliplatin toxicity masquerading as recurrent colon cancer.
IN REPLY: The letter of Dr Altundag et al raises a few important questions for the interpretation of circulating DNA levels. With respect to human telomerase reverse transcriptase (hTERT) specificity, it was not our intention to use hTERT genomic amplification as a tumor-associated marker, but instead, we simply used it as a marker to quantify , by real-time polymerase chain reaction, the total...
متن کاملStudy of subacute renal toxicity of Bisphenol A in rats
Background and Aims: Bisphenol A (BPA) falls in the category of hormonal disruptors due to its widespread application, and several studies have revealed its toxicity in different doses. However, few studies have investigated the effect of BPA on the renal system. Therefore, the present study aimed to investigate the effect of BPA on renal system function in rats. Materials and Methods: Initial...
متن کاملRenal tubular acidosis due to oxaliplatin.
Oxaliplatin is a third-generation platinum derivative which in combination with a fluoropyrimidine has demonstrated improved overall survival in metastatic colon cancer [1], prolonged progression free survival in an adjuvant setting [2] and prompted recommendations for its use by the National Institute for Clinical Excellence [3]. Initial studies with oxaliplatin did not identify significant re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2005
ISSN: 1460-2385,0931-0509
DOI: 10.1093/ndt/gfh826